Denna sida på svenska

Staffan Rosenborg

Associated

Visiting address : Avdelningen För Klinisk Farmakologi, C1:68, Karolinska Universitetssjukhuset 14186 Stockholm, Sweden
Postal address : Department of Laboratory Medicine (LABMED), H5, Division of Clinical Pharmacology, Avdelningen För Klinisk Farmakologi, C1:68, Karolinska Universtetssjukhuset, Huddinge 14186 Stockholm, Sweden
Delivery address : Avdelningen För Klinisk Farmakologi, C1:68, Karolinska Universitetssjukhuset 14186 Stockholm, Sweden

Publications

Ecological Effect of Solithromycin on Normal Human Oropharyngeal and Intestinal Microbiota
Rashid Mu, Rosenborg S, Panagiotidis G, Holm J, Söderberg Löfdal K, Weintraub A, et al
Antimicrobial agents and chemotherapy 2016;60(7):4244-51

Experiences from using LC-MS/MS for analysis of immunosuppressive drugs in a TDM service
Pohanka A, Rosenborg S, Lindh Jd, Beck O
Clinical biochemistry 2016;49(13-14):1024-31

Ecological Effect of Ceftaroline-Avibactam on the Normal Human Intestinal Microbiota
Rashid Mu, Rosenborg S, Panagiotidis G, Söderberg-löfdal K, Weintraub A, Nord Ce
Antimicrobial agents and chemotherapy 2015;59(8):4504-9

Ecological effect of ceftazidime/avibactam on the normal human intestinal microbiota
Rashid Mu, Rosenborg S, Panagiotidis G, Löfdal Ks, Weintraub A, Nord Ce
International journal of antimicrobial agents 2015;46(1):60-5

First report on the pharmacokinetics of tramadol and O-desmethyltramadol in exhaled breath compared to plasma and oral fluid after a single oral dose
Meyer Mr, Rosenborg S, Stenberg M, Beck O
Biochemical pharmacology 2015;98(3):502-10

High phenobarbital clearance during continuous renal replacement therapy: a case report and pharmacokinetic analysis
Rosenborg S, Saraste L, Wide K
Medicine 2014;93(7):e46-

Systematic conversion to generic tacrolimus in stable kidney transplant recipients
Rosenborg S, Nordström A, Almquist T, Wennberg L, Bárány P
Clinical kidney journal 2014;7(2):151-155

Characteristics and apprehensions of clinical pharmacologists in Swedish healthcare--a questionnaire study
Wallerstedt Sm, Rosenborg S
European journal of clinical pharmacology 2013;69 Suppl 1():95-9

New potential cell source for hepatocyte transplantation: discarded livers from metabolic disease liver transplants
Gramignoli R, Tahan V, Dorko K, Skvorak Kj, Hansel Mc, Zhao W, et al
Stem cell research 2013;11(1):563-73

[Unclear on dose adjustment in renal impairment]
Asker-hagelberg C, Rydberg D, Hentschke M, Holm L, Rosenborg S, Elinder Cg
Lakartidningen 2013;110(21):1030-2

Omeprazole limited sampling strategies to predict area under the concentration-time curve ratios: implications for cytochrome P450 2C19 and 3A phenotyping
Lawson Eb, Wu Jc, Baldwin Rm, Ingelman-sundberg M, Rosenborg S, Yim Ds, et al
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY 2012;68(4):407-13

Quantification of Tacrolimus and Three Demethylated Metabolites in Human Whole Blood Using LC-ESI-MS/MS
Dubbelboer Ir, Pohanka A, Said R, Rosenborg S, Beck O
THERAPEUTIC DRUG MONITORING 2012;34(2):134-42

[Can oseltamivir (Tamiflu) be used in dialysis-requiring renal failure?]
Rosenborg S
Lakartidningen 2010;107(3):116-7

Clinically Significant CYP2C Inhibition by Noscapine but Not by Glucosamine
Rosenborg S, Stenberg M, Otto S, Ostervall J, Masquelier M, Yue Qy, et al
CLINICAL PHARMACOLOGY & THERAPEUTICS 2010;88(3):343-6

[Cross reactivity between ACE inhibitors and angiotensin receptor blockers]
Rosenborg S
Lakartidningen 2010;107(7):444-

Increased omeprazole metabolism in carriers of the CYP2C19*17 allele; a pharmacokinetic study in healthy volunteers
Baldwin Rm, Ohlsson S, Pedersen Rs, Mwinyi J, Ingelman-sundberg M, Eliasson E, et al
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY 2008;65(5):767-74

Kinetics of omeprazole and escitalopram in relation to the CYP2C19*17 allele in healthy subjects
Rosenborg So, Mwinyi J, Andersson M, Baldwin Rm, Pedersen Rs, Sim Sc, et al
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY 2008;64(12):1175-9

Noscapine may increase the effect of warfarin
Ohlsson S, Holm L, Myrberg O, Sundstrom A, Yue Qy
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY 2008;65(2):277-8

Accumulation of celecoxib with a 7-fold higher drug exposure in individuals homozygous for CYP2C9*3
Lundblad Ms, Ohlsson S, Johansson P, Lafolie P, Eliasson E
CLINICAL PHARMACOLOGY & THERAPEUTICS 2006;79(3):287-8

Persistent B19 parvovirus infection in pediatric malignancies
Broliden K, Tolfvenstam T, Ohlsson S, Henter Ji
MEDICAL AND PEDIATRIC ONCOLOGY 1998;31(2):66-72

Immune responses to the HIV rev regulatory gene
Wahren B, Brytting Mm, Engström G, Hinkula J, Levi M, Ståhle El, et al
Antibiotics and chemotherapy 1996;48():105-12

Show all publications